Immunosuppression for COVID-19: repurposing medicines in a pandemic
Aust Prescr
.
2020 Aug;43(4):106-107.
doi: 10.18773/austprescr.2020.037.
Epub 2020 Jun 17.
Authors
Senthuran Shivakumar
1
2
3
,
Olivia C Smibert
1
2
3
,
Jason A Trubiano
1
2
3
,
Albert G Frauman
1
2
3
,
David Fl Liew
1
2
3
Affiliations
1
Austin Health, Melbourne.
2
University of Melbourne.
3
National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne.
PMID:
32921881
PMCID:
PMC7450778
DOI:
10.18773/austprescr.2020.037
No abstract available
Keywords:
COVID-19; immunosuppression; interleukin-1; interleukin-6; pandemic; tocilizumab.
Publication types
Editorial